ProfoundBio discovers the joys of having a wealthy owner
The company has become the latest in a recent string of China-related innovative drug makers to be purchased by larger foreign buyers Key Takeaways: Cancer treatment maker ProfoundBio announced it…
Recent Articles
RELATED ARTICLES
- CHINA BULLETIN: Weak Inflation, Producer Price Data Hint at Flagging Rebound
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
- InSilico seeks IPO boost to get AI drugs over the line
-
Everest reaches new heights on growing drug sales
1952.HK
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
Discover hidden China stock gems in our weekly newsletter